Value proposition

Model-Informed Drug Discovery and Development (MID3) services, software, and R&D company.

Founded in 2013, Applied BioMath uses mathematical modeling and simulation to provide quantitative and predictive guidance to biotechnology and pharmaceutical companies to help accelerate and de-risk drug research and development. Our Model-Aided Drug Invention (MADI) approach employs proprietary algorithms and software to support groups worldwide in decision-making from early research through clinical trials. The Applied BioMath team leverages their decades of expertise in biology, mathematical modeling and analysis, high-performance computing, and industry experience to help groups better understand their candidate, its best-in-class parameters, competitive advantages, patients, and the best path forward into and in the clinic. For more information about Applied BioMath and its services, visit www.appliedbiomath.com.

Mechanistic PK/PD, Quantitative Decision Making, Risk Assessments, Predict optimal drug properties for lead gen or clinical candidate selection, Phase 1 and Phase 2 support and analysis, and Technical Due Dilligence